Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0YQ8U
|
|||
| Former ID |
DNC006940
|
|||
| Drug Name |
(5-phenylfuran-2-yl)methanamine
|
|||
| Synonyms |
(5-phenylfuran-2-yl)methanamine; 39170-18-8; 2-Furanmethanamine, 5-phenyl-; 5-phenylfurfurylamine; AC1Q53ZI; SCHEMBL720013; (5-phenyl-2-furyl)methylamine; CHEMBL214859; CTK7E5186; BDBM12363; MolPort-004-306-048; 1-(5-phenyl-2-furyl)methanamine; ZINC14949858; nicotine 3-heteroaromatic analogue 22; AKOS000143046; MCULE-3484411839; AJ-65506; EN300-49879
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H11NO
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CC=C(O2)CN
|
|||
| InChI |
1S/C11H11NO/c12-8-10-6-7-11(13-10)9-4-2-1-3-5-9/h1-7H,8,12H2
|
|||
| InChIKey |
HQHHWOJYOUTZHZ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 39170-18-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Debrisoquine 4-hydroxylase (CYP2D6) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Metabolism of xenobiotics by cytochrome P450 | |||
| Drug metabolism - cytochrome P450 | ||||
| Serotonergic synapse | ||||
| Reactome | Xenobiotics | |||
| WikiPathways | Metapathway biotransformation | |||
| Tamoxifen metabolism | ||||
| Oxidation by Cytochrome P450 | ||||
| Vitamin D Receptor Pathway | ||||
| Aripiprazole Metabolic Pathway | ||||
| Fatty Acid Omega Oxidation | ||||
| Codeine and Morphine Metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J Med Chem. 2006 Nov 30;49(24):6987-7001. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.